A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial.The cornea ...

A new stem cell therapy, CALEC, has demonstrated a 92% success rate in regenerating corneas and restoring vision. This ...

Results from a Mass Eye and Ear-led phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 ...

In the context of a clinical trial, double-blind means that neither the patients nor the researchers know who is getting a placebo and who is getting the treatment. Because patients don't know ...

Stem cells from a healthy eye, when transplanted into a damaged eye, safely restored corneal surfaces in 14 patients who were followed for 18 months.

This review was only based on two moderate-sized trials. Blinding of patients was not performed in both trials, causing some risk of bias in outcome assessment since primary endpoints were wholly ...

Methods: Multicentre, randomised, double-blind, parallel-group clinical trial in 64 outpatients with GAD (DSM-IV criteria). Patients were assigned to mexazolam 1mg three times daily (n = 32 ...

An expanded phase clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries ...

A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. However, severe injuries, such as those caused by chemical burns or infections ...